Vitamin D in prostate cancer / 亚洲男科学杂志(英文版)
Asian Journal of Andrology
;
(6): 244-252, 2018.
Artículo
en Inglés
| WPRIM
| ID: wpr-1009601
ABSTRACT
Signaling through the vitamin D receptor has been shown to be biologically active and important in a number of preclinical studies in prostate and other cancers. Epidemiologic data also indicate that vitamin D signaling may be important in the cause and prognosis of prostate and other cancers. These data indicate that perturbation of vitamin D signaling may be a target for the prevention and treatment of prostate cancer. Large studies of vitamin D supplementation will be required to determine whether these observations can be translated into prevention strategies. This paper reviews the available data in the use of vitamin D compounds in the treatment of prostate cancer. Clinical data are limited which support the use of vitamin D compounds in the management of men with prostate cancer. However, clinical trials guided by existing preclinical data are limited.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Asunto principal:
Neoplasias de la Próstata
/
Vitamina D
/
Deficiencia de Vitamina D
/
Calcifediol
/
Calcitriol
/
Transducción de Señal
/
Protocolos de Quimioterapia Combinada Antineoplásica
/
Ergocalciferoles
/
Ensayos Clínicos como Asunto
Límite:
Humanos
/
Masculino
Idioma:
Inglés
Revista:
Asian Journal of Andrology
Año:
2018
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS